Date Published

September 2, 2021

Updated For

ALS PCS Version 5.2


New to the 2020 AHA guidelines is the preference for IV medication administration during ACLS, over IO administration.

A recent systematic review found better clinical outcome in patients that received ACLS drug administration via IV vs IO.


Consistent with the current ALS-PCS treatment, they state IO access is acceptable if IV access is unavailable.

For more great evidence based recommendations, check out your 2021 MCME Precourse module on the AHA Guidelines Update!


Additional Resources:

No additional resources available for this #SWORBHPTip.

Share this tip with others:

Select a platform: